Jul 17, 2026 | At-home colon cancer tests, Cancer, Colon Cancer, Colonoscopy, MedBen WellLiving, Wellness, Wellness screenings
The American Cancer Society has expanded colorectal cancer screening guidelines to include a new blood test and additional at-home stool options. The aim is greater accessibility, especially for those who might otherwise skip screening. However, the guidelines still...
Jul 7, 2026 | Cancer, Children, High-cost claims, Neonatal conditions, Stop-Loss
Tokio Marine HCC’s 2026 Annual Market Report shows children under age 10 now account for 39% of stop-loss claims exceeding $1 million — more than triple the share of any other 10-year age group. This concentrated risk creates new considerations for self-funded plans,...
Jun 17, 2026 | Cancer, Colon Cancer, Family doctors, Family health history, Preventive Care, Primary Care, Wellness
Knowing your family’s health history — and making sure your primary care physician knows it too — can make a real difference in catching serious conditions early. KFF Health News recently shared the story of a 33-year-old woman who discovered only after being...
May 27, 2026 | Cancer, Claims, Client Report, GLP-1s, Heart disease, Specialty Drugs, Stop-Loss, Trend
A new Sun Life analysis shows high-cost claims continue to strain employer health plans. The annual High-Cost Claims and Injectable Drug Trends report identifies comorbid conditions, long inpatient stays, and injectable specialty drugs as primary drivers of claims...
Apr 30, 2026 | Blood pressure, Breast cancer, Cancer, Cervical Cancer, Cholesterol, Chronic conditions, Emergency Room (ER), Hospitals, Preventive Care, Primary Care, Research, Study
Total health care expenditures for adults who have consistent access to a primary care provider (PCP) were nearly 54% lower than those without one, according to a recent analysis. Regular PCP access is strongly associated with higher rates of recommended preventive...
Feb 10, 2026 | Benefits Advisory Conference, Benefits management, Cancer, Caroline Fraker, Compliance, Forensic claims review, Gene therapy, GLP-1s, High-cost claims, MedBen University, No Surprises Act (NSA), Obesity, Orphan diseases, Pharmacy, Specialty Drugs, Stop-Loss, Transplants
Consultants and advisors from 10 different states attended the MedBen 2026 Benefits Advisory Conference on January 28. The event featured insights from some of the industry’s most respected voices and gave brokers a clearer view of today’s benefits landscape, what...
